Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Hyemyung Seo

Showing results (1-10 of 62) with videos related to

Pageof 7
Sort By:
Experimental Neurology|May 5, 2005
Abnormal APP, cholinergic and cognitive function in Ts65Dn Down's model miceHyemyung Seo, Ole Isacson
Biochemical and Biophysical Research Communications|December 17, 2013
Baclofen, a GABAB receptor agonist, enhances ubiquitin-proteasome system functioning and neuronal survival in Huntington's disease model miceWoori Kim, Hyemyung Seo
Journal of Neurochemistry|August 12, 2010
The hAPP-YAC transgenic model has elevated UPS activity in the frontal cortex similar to Alzheimer's disease and Down's syndromeHyemyung Seo, Ole Isacson
Human Molecular Genetics|July 22, 2008
Compensatory changes in the ubiquitin-proteasome system, brain-derived neurotrophic factor and mitochondrial complex II/III in YAC72 and R6/2 transgenic mice partially model Huntington's disease patientsHyemyung Seo, Woori Kim, Ole Isacson
Neurochemistry International|March 11, 2014
Systemic injection of LPS induces region-specific neuroinflammation and mitochondrial dysfunction in normal mouse brainHaneul Noh, Jeha Jeon, Hyemyung Seo
Annals of Neurology|September 7, 2004
Generalized brain and skin proteasome inhibition in Huntington's diseaseHyemyung Seo, Kai-Christian Sonntag, Ole Isacson
The European Journal of Neuroscience|March 6, 2002
Cortico-hippocampal APP and NGF levels are dynamically altered by cholinergic muscarinic antagonist or M1 agonist treatment in normal miceHyemyung Seo, Andrew W Ferree, Ole Isacson
International Journal of Molecular Sciences|March 13, 2025
Brain Disease-Modifying Effects of Radiofrequency as a Non-Contact Neuronal Stimulation TechnologyShulei Sun, Junsoo Bok, Yongwoo Jang, et al.
Experimental Neurobiology|September 9, 2019
HDAC Inhibition by Valproic Acid Induces Neuroprotection and Improvement of PD-like Behaviors in LRRK2 R1441G Transgenic MiceTaewoo Kim, Seohoe Song, Yeongwon Park, et al.
Neuroscience Letters|February 24, 2007
SB203580 enhances interleukin-1 receptor antagonist gene expression in IFN-gamma-stimulated BV2 microglial cells through a composite nuclear factor-kappaB/PU.1 binding siteJin-Sun Park, Soo-Hyun Jung, Hyemyung Seo, et al.
Pageof 7

Showing results (1-10 of 62) with videos related to

Sort By:
Pageof 7
Experimental Neurology|May 5, 2005
Abnormal APP, cholinergic and cognitive function in Ts65Dn Down's model miceHyemyung Seo, Ole Isacson
Biochemical and Biophysical Research Communications|December 17, 2013
Baclofen, a GABAB receptor agonist, enhances ubiquitin-proteasome system functioning and neuronal survival in Huntington's disease model miceWoori Kim, Hyemyung Seo
Journal of Neurochemistry|August 12, 2010
The hAPP-YAC transgenic model has elevated UPS activity in the frontal cortex similar to Alzheimer's disease and Down's syndromeHyemyung Seo, Ole Isacson
Human Molecular Genetics|July 22, 2008
Compensatory changes in the ubiquitin-proteasome system, brain-derived neurotrophic factor and mitochondrial complex II/III in YAC72 and R6/2 transgenic mice partially model Huntington's disease patientsHyemyung Seo, Woori Kim, Ole Isacson
Neurochemistry International|March 11, 2014
Systemic injection of LPS induces region-specific neuroinflammation and mitochondrial dysfunction in normal mouse brainHaneul Noh, Jeha Jeon, Hyemyung Seo
Annals of Neurology|September 7, 2004
Generalized brain and skin proteasome inhibition in Huntington's diseaseHyemyung Seo, Kai-Christian Sonntag, Ole Isacson
The European Journal of Neuroscience|March 6, 2002
Cortico-hippocampal APP and NGF levels are dynamically altered by cholinergic muscarinic antagonist or M1 agonist treatment in normal miceHyemyung Seo, Andrew W Ferree, Ole Isacson
International Journal of Molecular Sciences|March 13, 2025
Brain Disease-Modifying Effects of Radiofrequency as a Non-Contact Neuronal Stimulation TechnologyShulei Sun, Junsoo Bok, Yongwoo Jang, et al.
Experimental Neurobiology|September 9, 2019
HDAC Inhibition by Valproic Acid Induces Neuroprotection and Improvement of PD-like Behaviors in LRRK2 R1441G Transgenic MiceTaewoo Kim, Seohoe Song, Yeongwon Park, et al.
Neuroscience Letters|February 24, 2007
SB203580 enhances interleukin-1 receptor antagonist gene expression in IFN-gamma-stimulated BV2 microglial cells through a composite nuclear factor-kappaB/PU.1 binding siteJin-Sun Park, Soo-Hyun Jung, Hyemyung Seo, et al.
Pageof 7